Oui, un statut socio-économique plus bas peut être associé à un risque accru d'infection.
Statut socio-économiqueTrichomonas vaginalis
#5
Les femmes ayant des partenaires multiples sont-elles à risque ?
Oui, les femmes ayant plusieurs partenaires sexuels sont à risque accru d'infection.
Partenaires multiplesInfections à protozoaires
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Trichomonas vaginalis : Questions médicales les plus fréquentes",
"headline": "Trichomonas vaginalis : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Trichomonas vaginalis : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-26",
"dateModified": "2026-02-15",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Trichomonas vaginalis"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Trichomonas",
"url": "https://questionsmedicales.fr/mesh/D014244",
"about": {
"@type": "MedicalCondition",
"name": "Trichomonas",
"code": {
"@type": "MedicalCode",
"code": "D014244",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.630.800.808"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Trichomonas vaginalis",
"alternateName": "Trichomonas vaginalis",
"code": {
"@type": "MedicalCode",
"code": "D014246",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Jae-Sook Ryu",
"url": "https://questionsmedicales.fr/author/Jae-Sook%20Ryu",
"affiliation": {
"@type": "Organization",
"name": "Department of Environmental Biology and Medical Parasitology, Hanyang University College of Medicine, Seoul 04763, Korea."
}
},
{
"@type": "Person",
"name": "Marlene Benchimol",
"url": "https://questionsmedicales.fr/author/Marlene%20Benchimol",
"affiliation": {
"@type": "Organization",
"name": "Universidade do Grande Rio, Duque de Caxias, Brazil; Laboratório de Ultraestrutura Celular Hertha Meyer, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Centro de Ciências da Saúde, Bloco G, Rio de Janeiro, Brazil; Instituto Nacional de Ciência e Tecnologia and Centro Nacional de Biologia Estrutural e Bioimagem, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil; CMABio da Escola Superior de Saúde, Universidade do Estado do Amazonas, Manaus, Amazonas, Brazil. Electronic address: marlenebenchimol@gmail.com."
}
},
{
"@type": "Person",
"name": "Jan Tachezy",
"url": "https://questionsmedicales.fr/author/Jan%20Tachezy",
"affiliation": {
"@type": "Organization",
"name": "Department of Parasitology, Faculty of Science, Charles University, BIOCEV, Vestec, Czech Republic."
}
},
{
"@type": "Person",
"name": "Wanderley de Souza",
"url": "https://questionsmedicales.fr/author/Wanderley%20de%20Souza",
"affiliation": {
"@type": "Organization",
"name": "Laboratório de Ultraestrutura Celular Hertha Meyer, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Centro de Ciências da Saúde, Bloco G, Rio de Janeiro, Brazil; Instituto Nacional de Ciência e Tecnologia and Centro Nacional de Biologia Estrutural e Bioimagem, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil; CMABio da Escola Superior de Saúde, Universidade do Estado do Amazonas, Manaus, Amazonas, Brazil."
}
},
{
"@type": "Person",
"name": "Abhijith Makki",
"url": "https://questionsmedicales.fr/author/Abhijith%20Makki",
"affiliation": {
"@type": "Organization",
"name": "Department of Parasitology, Faculty of Science, Charles University, BIOCEV, Vestec, Czech Republic."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Effects of SQ109 on Trichomonas vaginalis.",
"datePublished": "2023-05-16",
"url": "https://questionsmedicales.fr/article/37196704",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.exppara.2023.108549"
}
},
{
"@type": "ScholarlyArticle",
"name": "Stimulation of microvesicle secretion in Trichomonas vaginalis.",
"datePublished": "2024-02-21",
"url": "https://questionsmedicales.fr/article/38395187",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.exppara.2024.108722"
}
},
{
"@type": "ScholarlyArticle",
"name": "Transcriptional profile of Trichomonas vaginalis in response to metronidazole.",
"datePublished": "2023-06-12",
"url": "https://questionsmedicales.fr/article/37308818",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12864-023-09339-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Phenolic chalcones as agents against Trichomonas vaginalis.",
"datePublished": "2023-09-28",
"url": "https://questionsmedicales.fr/article/37839143",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.bioorg.2023.106888"
}
},
{
"@type": "ScholarlyArticle",
"name": "Disparities in adherence to retesting guidelines in women with Trichomonas vaginalis infection.",
"datePublished": "2023-06-29",
"url": "https://questionsmedicales.fr/article/37393012",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ajog.2023.06.045"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Eucaryotes",
"item": "https://questionsmedicales.fr/mesh/D056890"
},
{
"@type": "ListItem",
"position": 3,
"name": "Parabasalidea",
"item": "https://questionsmedicales.fr/mesh/D056900"
},
{
"@type": "ListItem",
"position": 4,
"name": "Trichomonadida",
"item": "https://questionsmedicales.fr/mesh/D016834"
},
{
"@type": "ListItem",
"position": 5,
"name": "Trichomonas",
"item": "https://questionsmedicales.fr/mesh/D014244"
},
{
"@type": "ListItem",
"position": 6,
"name": "Trichomonas vaginalis",
"item": "https://questionsmedicales.fr/mesh/D014246"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Trichomonas vaginalis - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Trichomonas vaginalis",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Trichomonas vaginalis",
"description": "Comment diagnostiquer une infection à Trichomonas vaginalis ?\nQuels tests sont utilisés pour le diagnostic ?\nLes tests sanguins sont-ils utiles pour le diagnostic ?\nPeut-on diagnostiquer l'infection par auto-examen ?\nLes symptômes aident-ils au diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D014246#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Trichomonas vaginalis",
"description": "Quels sont les symptômes courants de l'infection ?\nL'infection peut-elle être asymptomatique ?\nLes hommes peuvent-ils avoir des symptômes ?\nComment se manifestent les pertes vaginales ?\nY a-t-il des symptômes associés à d'autres infections ?",
"url": "https://questionsmedicales.fr/mesh/D014246#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Trichomonas vaginalis",
"description": "Comment prévenir l'infection à Trichomonas vaginalis ?\nLes tests réguliers sont-ils recommandés ?\nL'hygiène personnelle aide-t-elle à prévenir l'infection ?\nLes femmes enceintes doivent-elles se faire tester ?\nLes douches vaginales sont-elles recommandées ?",
"url": "https://questionsmedicales.fr/mesh/D014246#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Trichomonas vaginalis",
"description": "Quel est le traitement standard pour l'infection ?\nLe traitement est-il le même pour les hommes et les femmes ?\nLes partenaires doivent-ils être traités aussi ?\nY a-t-il des effets secondaires au traitement ?\nLe traitement est-il efficace ?",
"url": "https://questionsmedicales.fr/mesh/D014246#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Trichomonas vaginalis",
"description": "Quelles complications peuvent survenir si non traitée ?\nL'infection peut-elle affecter la fertilité ?\nY a-t-il un risque accru de VIH ?\nLes complications sont-elles plus graves chez les femmes ?\nLes hommes peuvent-ils avoir des complications ?",
"url": "https://questionsmedicales.fr/mesh/D014246#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Trichomonas vaginalis",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque d'infection ?\nLes antécédents d'infections sexuellement transmissibles augmentent-ils le risque ?\nLe statut socio-économique joue-t-il un rôle ?\nLes femmes ayant des partenaires multiples sont-elles à risque ?",
"url": "https://questionsmedicales.fr/mesh/D014246#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection à Trichomonas vaginalis ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par un examen microscopique des sécrétions vaginales ou urinaires."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de culture, PCR ou des tests rapides peuvent être utilisés pour confirmer l'infection."
}
},
{
"@type": "Question",
"name": "Les tests sanguins sont-ils utiles pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les tests sanguins ne sont pas utilisés pour diagnostiquer Trichomonas vaginalis."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer l'infection par auto-examen ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, un examen médical est nécessaire pour un diagnostic précis de l'infection."
}
},
{
"@type": "Question",
"name": "Les symptômes aident-ils au diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent orienter le diagnostic, mais un test est nécessaire pour confirmation."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de l'infection ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des démangeaisons, des pertes vaginales anormales et des douleurs lors des rapports."
}
},
{
"@type": "Question",
"name": "L'infection peut-elle être asymptomatique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, de nombreuses personnes infectées par Trichomonas vaginalis ne présentent pas de symptômes."
}
},
{
"@type": "Question",
"name": "Les hommes peuvent-ils avoir des symptômes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les hommes peuvent avoir des symptômes comme des douleurs lors de la miction ou des écoulements."
}
},
{
"@type": "Question",
"name": "Comment se manifestent les pertes vaginales ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les pertes peuvent être mousseuses, de couleur jaunâtre ou verdâtre, avec une odeur désagréable."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes associés à d'autres infections ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent être similaires à ceux d'autres infections sexuellement transmissibles."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'infection à Trichomonas vaginalis ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'utilisation de préservatifs lors des rapports sexuels peut réduire le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les tests réguliers sont-ils recommandés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests réguliers pour les infections sexuellement transmissibles sont conseillés."
}
},
{
"@type": "Question",
"name": "L'hygiène personnelle aide-t-elle à prévenir l'infection ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une bonne hygiène personnelle peut aider, mais ne remplace pas l'utilisation de préservatifs."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes doivent-elles se faire tester ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes enceintes doivent être testées pour Trichomonas vaginalis pour éviter des complications."
}
},
{
"@type": "Question",
"name": "Les douches vaginales sont-elles recommandées ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les douches vaginales ne sont pas recommandées et peuvent perturber la flore vaginale."
}
},
{
"@type": "Question",
"name": "Quel est le traitement standard pour l'infection ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement standard est l'administration de métronidazole ou de tinidazole par voie orale."
}
},
{
"@type": "Question",
"name": "Le traitement est-il le même pour les hommes et les femmes ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le traitement est généralement le même pour les hommes et les femmes infectés."
}
},
{
"@type": "Question",
"name": "Les partenaires doivent-ils être traités aussi ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est recommandé que les partenaires sexuels soient également traités pour éviter la réinfection."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires au traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des nausées, des maux de tête et des réactions allergiques."
}
},
{
"@type": "Question",
"name": "Le traitement est-il efficace ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le traitement est généralement très efficace, avec un taux de guérison élevé."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir si non traitée ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Sans traitement, l'infection peut entraîner des complications comme des infections pelviennes."
}
},
{
"@type": "Question",
"name": "L'infection peut-elle affecter la fertilité ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une infection non traitée peut augmenter le risque de problèmes de fertilité chez les femmes."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de VIH ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes infectées par Trichomonas vaginalis peuvent avoir un risque accru de contracter le VIH."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles plus graves chez les femmes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes peuvent éprouver des complications plus graves, notamment des douleurs pelviennes."
}
},
{
"@type": "Question",
"name": "Les hommes peuvent-ils avoir des complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, bien que moins fréquentes, les hommes peuvent également développer des complications comme l'urétrite."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent des rapports sexuels non protégés et un nombre élevé de partenaires sexuels."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'infection ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes adultes, en particulier les femmes, sont plus à risque d'infection."
}
},
{
"@type": "Question",
"name": "Les antécédents d'infections sexuellement transmissibles augmentent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, avoir des antécédents d'autres infections sexuellement transmissibles augmente le risque."
}
},
{
"@type": "Question",
"name": "Le statut socio-économique joue-t-il un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un statut socio-économique plus bas peut être associé à un risque accru d'infection."
}
},
{
"@type": "Question",
"name": "Les femmes ayant des partenaires multiples sont-elles à risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes ayant plusieurs partenaires sexuels sont à risque accru d'infection."
}
}
]
}
]
}
Department of Environmental Biology and Medical Parasitology, Hanyang University College of Medicine, Seoul 04763, Korea.
Department of Biomedical Science, Hanyang University Graduate School of Biomedical Science and Engineering, Hanyang University College of Medicine, Seoul 04763, Korea.
Universidade do Grande Rio, Duque de Caxias, Brazil; Laboratório de Ultraestrutura Celular Hertha Meyer, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Centro de Ciências da Saúde, Bloco G, Rio de Janeiro, Brazil; Instituto Nacional de Ciência e Tecnologia and Centro Nacional de Biologia Estrutural e Bioimagem, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil; CMABio da Escola Superior de Saúde, Universidade do Estado do Amazonas, Manaus, Amazonas, Brazil. Electronic address: marlenebenchimol@gmail.com.
Laboratório de Ultraestrutura Celular Hertha Meyer, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Centro de Ciências da Saúde, Bloco G, Rio de Janeiro, Brazil; Instituto Nacional de Ciência e Tecnologia and Centro Nacional de Biologia Estrutural e Bioimagem, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil; CMABio da Escola Superior de Saúde, Universidade do Estado do Amazonas, Manaus, Amazonas, Brazil.
Universidade do Grande Rio, Duque de Caxias, Brazil; Laboratório de Ultraestrutura Celular Hertha Meyer, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Centro de Ciências da Saúde, Bloco G, Rio de Janeiro, Brazil; Instituto Nacional de Ciência e Tecnologia and Centro Nacional de Biologia Estrutural e Bioimagem, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Department of Biomedical Sciences, College of Medicine, Chang Gung University, Guishan District, Taoyuan City, Taiwan; Genomic Medicine Core Laboratory, Chang Gung Memorial Hospital, Linkou, Taiwan. Electronic address: pjhuang@gap.cgu.edu.tw.
Department of Parasitology, College of Medicine, Chang Gung University, Guishan District, Taoyuan City, Taiwan; Molecular Infectious Disease Research Center, Chang Gung Memorial Hospital, Linkou, Taiwan. Electronic address: petang@mail.cgu.edu.tw.
Department of Environmental Biology and Medical Parasitology, Hanyang University College of Medicine, Seoul 04763, Korea.
Department of Biomedical Science, Hanyang University Graduate School of Biomedical Science and Engineering, Hanyang University College of Medicine, Seoul 04763, Korea.
Trichomonas vaginalis is a protozoan that causes human trichomoniasis, a sexually transmitted infection (STI) that affects approximately 278 million people worldwide. The current treatment for human t...
Trichomonas vaginalis is an extracellular flagellate protozoan and the etiological agent of human trichomoniasis, a sexually transmitted infection (STI) with a high incidence. Several reports have sho...
Trichomoniasis caused by Trichomonas vaginalis, combined with its complications, has long frequently damaged millions of human health. Metronidazole (MTZ) is the first choice for therapy. Therefore, a...
The results showed that the morphology and subcellular structures of T. vaginalis underwent prominent alterations, characterized by a rough surface with bubbly protrusions, broken holes and deformed n...
The current study reveals evident nuclear and cytomembrane damage and multiple variations in T. vaginalis at the transcriptional level. These data will offer a meaningful foundation for a deeper under...
Trichomonas vaginalis, a flagellated and anaerobic protozoan, is a causative agent of trichomoniasis. This disease is among the world's most common non-viral sexually transmitted infection. A single c...
Trichomoniasis is the most prevalent nonviral sexually transmitted infection in the United States. Numerous studies have shown disproportionately higher prevalence rates in non-Hispanic Black women. B...
This study aimed to describe Trichomonas vaginalis infection rates, evaluate adherence to retesting guidelines, and examine characteristics of women who were not retested according to the guidelines i...
We conducted a retrospective cohort study of patients from a single hospital-based obstetrics and gynecology clinic who were tested for Trichomonas vaginalis between January 1, 2015 and December 31, 2...
Among the 8809 patients tested for Trichomonas vaginalis, 799 (9.1%) tested positive at least once during the study. Factors associated with trichomoniasis included identifying as non-Hispanic Black (...
Trichomonas vaginalis infection was identified at a high frequency in a diverse, urban hospital-based obstetrics and gynecology clinic population. Opportunities exist to improve on equitable and guide...
Hydrogenosomes are a specific type of mitochondria that have adapted for life under anaerobiosis. Limited availability of oxygen has resulted in the loss of the membrane-associated respiratory chain, ...
We report unprecedented modification of TIM in hydrogenosomes of the human parasite Trichomonas vaginalis (TvTIM). We show that the import of the presequence-containing protein into the hydrogenosomal...
The hybrid TvTIM in hydrogenosomes represents an original structural solution that evolved for protein import when Δψ is negligible and remarkable example of evolutionary adaptation to an anaerobic li...
The evidence in the literature regarding the relationship between Trichomonas vaginalis (TV) infection and cervical neoplasia is conflicting. The main aim of this study was to evaluate the magnitude o...
A meta-analysis of observational studies, which provided raw data on the association of TV infection with cervical neoplasia, was performed. For this aim, we searched scientific databases (PubMed/Medl...
Of the 2584 records initially identified, 35 eligible studies contributed data for 67,856 women with cervical neoplasia, and 933,697 healthy controls from 14 countries were included. The pooled (2.15;...
Our findings indicated that women with a TV infection are at significantly greater risk of cervical neoplasia. Future research, particularly longitudinal and experimental studies, should be done to be...
Trichomonas vaginalis (TV) accounts for the highest burden of curable, non-viral sexually transmitted infections worldwide. Prevalence in India ranges from 0.4 to 27.4% in women and 0.0-5.6% in men. I...
Six-hundred adult, sexually active women attending the Obstetrics-Gynaecology rural out-patient clinic the Rural Unit for Health and Social Affairs (RUHSA) from July 2020 - February 2021 were enrolled...
Nine specimens (9/600, 1.5%) were positive for TV. There was a 100% correlation between Biomed InPouch TV...
Current hospital-based prevalence of TV in rural Vellore was 1.5%. Repetitive DNA target TVK 3/7 was more sensitive than AP65 and BTUB 9/2 primers....
Cytoadherence and migration are crucial for pathogens to establish colonization in the host. In contrast to a nonadherent isolate of Trichomonas vaginalis, an adherent one expresses more actin-related...
Iron is an essential element for cellular functions, such as energy metabolism. Trichomonas vaginalis, a human urogenital tract pathogen, is capable of surviving in the environment without sufficient ...
In the present work, we conducted an LC‒MS-based metabolomics analysis to obtain accurate insights into the enzymatic events of T. vaginalis under iron-depleted (ID) conditions....
First, we showed the possible digestion of glycogen, cellulose polymerization, and accumulation of raffinose family oligosaccharides (RFOs). Second, a medium-chain fatty acid (MCFA), capric acid, was ...
These findings highlighted the possible glycogen utilization, cellulose biosynthesis, and fatty acid incorporation in pseudocyst formation as well as NO precursor ammonia production induced by iron-de...